Glenzocimab Biosimilar - Research Grade

Human

GP6ï؟½

5mg/ml

Fab - G1 - kappa

CHO Cells

https://www.imgt.org/mAb-DB/

ICH3002

Q9HCN6

Blue ice

Platelet glycoprotein VI (GPVI), the collagen receptor encoded by GP6, is central to platelet activation and thrombus formation and a compelling target in thrombosis research. Our research-grade anti-GPVI Fab is an unconjugated, non-therapeutic analog of glenzocimab, developed exclusively for research use only (RUO). Engineered to meet in vivo standards, this ultra-pure, low-endotoxin reagent ships in scalable milligram (mg) to gram (g) quantities to serve heavy-usage and high-throughput laboratories. It functions as a dependable reagent for platelet-function and receptor-blocking assays, collagen-binding inhibition studies, in vitro screening, and in vivo thrombosis models.

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

3-4 weeks